Updated:
Kindred Biosciences, Inc.
Kindred Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001561743, and its reported...
Overview
Kindred Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001561743, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2021-03-16, it reported annual revenue of USD 42,164,000; net income of USD -21,796,000; total assets of USD 95,814,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Kindred Biosciences, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Burlingame, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001561743
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2020USD | $42.2M | -$21.8M | $95.8M | $11.6M | -$9.9M | |
| FY2019USD | $4.3M | -$61.4M | $114.0M | $16.0M | -$56.3M | |
| FY2018USD | $2.0M | -$49.7M | $106.5M | $56.3M | -$45.0M | |
| FY2017USD | — | -$30.9M | $90.8M | $34.8M | -$21.9M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| SC 13D | — | Form SC 13D | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13D | — | SC 13D | |
| SC 13D | — | SC 13D | |
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Kindred Biosciences, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.